Ac immune sa

Major-Pharmaceuticals

ACIU


EPFL Innovation Park
Lausanne , 1015

Executive/
Director

Price

  • Last Close
  • $ 3.16
    $ -0.03 -0.79 %
    Dec 6, 2024
  • 52-Week High/Low
  • $5 - $2.36
  • YTD
  • -36.9%

  • Trading Volume
  • 2,062
  • Market Cap Full
  • $ 264.2M
  • Shares Outstanding
  • 83.6M
    Dec 31, 2022
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - -20.2% -19.2% -46.6% -5% 48.6% -21% 14.7% -40.8%
Q2 - - -15.1% 0.3% 11.6% 4% 4.2% -9.8% 26.3% -1.1%
Q3 - 5.2% 26.9% -14.2% -9.9% 8% -15.3% -12.5% -3.6% -
Q4 - -21.2% 13.7% 17% 73% 4.5% -24.7% -35.4% 76.1% -
J F M A M J J A S O N D
2024 -35.8% 12.8% -18.2% -8.8% - - - - - - - -
2023 21.6% -7.7% 2.2% -17.1% 12.4% 35.6% 1.5% 8.3% -12.3% 5.3% 10.3% 51.1%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%-1%-26%-10%-40%-1%-60%145%-37%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - 0.17 -0.21 0.91 - - - -0.23
Q2 - - 0.22 -0.19 -0.24 - - - -0.22
Q3 - - 0.16 -0.21 0.25 - - - -0.20
Q4 - - 0.06 -0.22 0.64 -0.92 -1.06 -0.24 -
A 0 0 0.6 -0.8 1.6 -0.92 -1.1 -0.9 -0.65

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - - - - -
Jun - - - - -
Sep - - - - -
Dec 67.6 71.9 71.9 83.5 83.6

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 1 - 3.2 28 2.3
Total Asset Turnover - - 0.1 0.4 -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - 14.3 -65 -45 -51
Equity multiplier - - - - -